66301-15-3

Usage

Uses

Used in Pharmaceutical Development:
2,5-dihydroxy-3-(piperidin-1-yl)-6-(pyridin-1(2H)-yl)cyclohexa-2,5-diene-1,4-dione is used as a pharmaceutical agent for its potential anti-cancer properties. Its unique structure allows it to interact with biological targets, offering a new avenue for the development of cancer treatments.
Used in Anti-Inflammatory Drug Development:
In the field of anti-inflammatory drug development, 2,5-dihydroxy-3-(piperidin-1-yl)-6-(pyridin-1(2H)-yl)cyclohexa-2,5-diene-1,4-dione is utilized for its potential to modulate inflammatory responses. Its heterocyclic nature may contribute to its effectiveness in managing inflammation-related conditions.
Used in Medicinal Chemistry Research:
2,5-dihydroxy-3-(piperidin-1-yl)-6-(pyridin-1(2H)-yl)cyclohexa-2,5-diene-1,4-dione serves as a subject of study in medicinal chemistry research. Its exploration can lead to a better understanding of the compound's mechanisms of action and potential applications in drug discovery and design.

Upstream product

• 110-86-1 pyridine 
• 488-48-2 tetrabromobenzoquinone 
• 118-75-2 chloranil 
• 123-31-9 hydroquinone 

Relevant academic research and scientific papers

Photocatalytically active materials with pyridinium-enolate partial structures

2,3-Dichloro-1,4-naphthoquinone and tetrabromo- or tetrachloro-1,4- benzoquinone were converted into pyridinium enolate betaines by reaction with pyridine or 4,4′-bipyridine. The reaction conditions were applied to poly-(4-vinylpyridine) and a modified Me

Synthesis and properties of dipyridemium betaines of derivatives of 1,4-benzoquinone and tetracyanoquinodimethane

Reaction of chloranil with excess pyridine gives the poorly stable 2,5-di(N-pyridinium)-3,6-dichloro-1,4-benzoquinone dichloride which is readily hydrolyzed to give the bisbetaine of 2,5-di(N-pyridinium)-1,4-benzoquinone-3,6-dioxide. Treatment with acid g